Dr. Lori Trefts, M.D

NPI: 1306875117
Total Payments
$24,016
2024 Payments
$2,893
Companies
71
Transactions
867
Medicare Patients
2,638
Medicare Billing
$387,601

Payment Breakdown by Category

Food & Beverage$17,179 (71.5%)
Consulting$4,550 (18.9%)
Other$1,152 (4.8%)
Travel$1,065 (4.4%)
Education$70.19 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $17,179 840 71.5%
Consulting Fee $4,550 6 18.9%
Travel and Lodging $1,065 4 4.4%
Honoraria $900.00 1 3.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $252.17 13 1.1%
Education $70.19 3 0.3%

Top Paying Companies

Company Total Records Latest Year
Genentech, Inc. $4,954 7 $0 (2018)
Biogen, Inc. $1,460 56 $0 (2024)
Genentech USA, Inc. $1,052 50 $0 (2024)
ABBVIE INC. $966.07 53 $0 (2024)
BANNER LIFE SCIENCES, LLC $911.67 2 $0 (2021)
UCB, Inc. $864.33 38 $0 (2024)
Novartis Pharmaceuticals Corporation $819.65 47 $0 (2024)
EMD Serono, Inc. $728.81 37 $0 (2024)
Eisai Inc. $633.14 27 $0 (2024)
Alexion Pharmaceuticals, Inc. $556.28 25 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,893 112 ABBVIE INC. ($342.29)
2023 $2,645 106 Biogen, Inc. ($319.92)
2022 $1,884 104 ABBVIE INC. ($190.87)
2021 $2,464 81 BANNER LIFE SCIENCES, LLC ($911.67)
2020 $964.99 57 Adamas Pharmaceuticals, Inc. ($137.12)
2019 $2,509 125 Biogen, Inc. ($292.17)
2018 $8,039 166 Genentech, Inc. ($4,916)
2017 $2,618 116 UCB, Inc. ($360.84)

All Payment Transactions

867 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
12/17/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $23.30 General
Category: NEUROLOGY
12/16/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $18.09 General
Category: Neurology
12/05/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $22.54 General
12/03/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $26.70 General
Category: Rare Disease
12/03/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $15.77 General
Category: Inflammation/Rare Disease
12/02/2024 Genentech USA, Inc. Ocrevus Zunovo (Biological) Food and Beverage In-kind items and services $30.83 General
Category: Immunology
11/22/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $14.04 General
Category: PAIN
11/21/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $25.95 General
Category: Immunology
11/19/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Food and Beverage In-kind items and services $20.52 General
Category: Neurology
11/18/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $16.86 General
Category: NEUROLOGY
11/12/2024 SK Life Science, Inc. Food and Beverage In-kind items and services $14.91 General
11/07/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $16.41 General
Category: PSYCHIATRY
11/05/2024 MITSUBISHI TANABE PHARMA AMERICA, INC. RADICAVA (Drug), RADICAVA ORS Food and Beverage In-kind items and services $26.48 General
Category: AMYOTROPHIC LATERAL SCLEROSIS
11/04/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $22.22 General
Category: Rare Disease
11/01/2024 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $272.78 General
Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA
10/31/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $26.54 General
Category: BOTOX THERAPEUTIC
10/22/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $15.86 General
Category: PAIN
10/17/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Food and Beverage In-kind items and services $22.86 General
Category: Neurology
10/15/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $17.72 General
Category: Neurology
10/08/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $26.35 General
Category: Rare Disease
10/07/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $19.57 General
Category: NEUROLOGY
10/04/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $20.17 General
Category: BOTOX THERAPEUTIC
10/03/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $13.54 General
Category: IMMUNOLOGY
10/01/2024 Lilly USA, LLC AMYVID (Drug), KISUNLA Food and Beverage In-kind items and services $17.78 General
Category: Neuroscience
09/30/2024 Vanda Pharmaceuticals Inc. PONVORY (Drug) Food and Beverage In-kind items and services $24.60 General
Category: MULTIPLE SCLEROSIS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 633 774 $183,548 $77,566
2022 13 645 6,297 $257,615 $111,221
2021 11 692 885 $214,336 $93,323
2020 14 668 6,755 $270,325 $105,491
Total Patients
2,638
Total Services
14,711
Medicare Billing
$387,601
Procedure Codes
48

All Medicare Procedures & Services

48 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 168 231 $55,314 $28,619 51.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 139 159 $28,991 $12,503 43.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 92 92 $31,372 $11,532 36.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 68 87 $18,183 $7,853 43.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 55 77 $10,934 $4,625 42.3%
99291 Critical care, first 30-74 minutes Facility 2023 13 28 $15,848 $4,611 29.1%
99483 Assessment of and care planning for patient with impaired thought processing, typically 60 minutes Office 2023 19 19 $8,303 $3,061 36.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 17 17 $5,680 $2,200 38.7%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2023 36 37 $5,143 $1,457 28.3%
95819 Measurement of brain wave activity (eeg), awake and asleep Facility 2023 26 27 $3,780 $1,105 29.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 167 228 $53,352 $28,707 53.8%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 11 5,500 $66,000 $26,901 40.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 115 144 $24,624 $11,381 46.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 65 68 $23,188 $9,535 41.1%
99483 Assessment of and care planning for impaired thought processing, typically 50 minutes Office 2022 50 50 $21,850 $9,066 41.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 63 98 $20,482 $7,641 37.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 45 45 $14,985 $6,636 44.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 41 65 $9,230 $3,507 38.0%
99291 Critical care, first 30-74 minutes Facility 2022 12 19 $10,754 $3,212 29.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 21 21 $5,502 $2,314 42.1%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2022 26 27 $3,753 $1,125 30.0%
95819 Measurement of brain wave activity (eeg), awake and asleep Facility 2022 17 17 $2,380 $748.99 31.5%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 12 15 $1,515 $447.15 29.5%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 154 227 $53,118 $29,277 55.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 115 118 $40,238 $17,784 44.2%

About Dr. Lori Trefts, M.D

Dr. Lori Trefts, M.D is a Neurology healthcare provider based in Brunswick, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306875117.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lori Trefts, M.D has received a total of $24,016 in payments from pharmaceutical and medical device companies, with $2,893 received in 2024. These payments were reported across 867 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($17,179).

As a Medicare-enrolled provider, Trefts has provided services to 2,638 Medicare beneficiaries, totaling 14,711 services with total Medicare billing of $387,601. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Other Specialties Neurology
  • Location Brunswick, GA
  • Active Since 07/02/2006
  • Last Updated 09/09/2015
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1306875117

Products in Payments

  • OCREVUS (Biological) $5,642
  • TYSABRI (Biological) $1,299
  • BAFIERTAM (Drug) $911.67
  • Briviact (Drug) $605.81
  • GOCOVRI (Drug) $588.01
  • UBRELVY (Drug) $504.20
  • NUEDEXTA (Drug) $468.29
  • ACTHAR (Biological) $460.74
  • Fycompa (Drug) $452.91
  • Reveal LINQ (Device) $440.19
  • Aimovig (Biological) $430.13
  • Hizentra (Biological) $397.07
  • NURTEC ODT (Drug) $380.02
  • ZEPOSIA (Drug) $379.91
  • BOTOX (Biological) $357.35
  • PURIFIED CORTROPHIN GEL (Drug) $344.00
  • VNS Therapy (Device) $341.60
  • KESIMPTA (Drug) $327.90
  • APTIOM (Drug) $324.31
  • ULTOMIRIS (Biological) $308.21

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Brunswick